Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
GEVO vs LMT vs RTX vs VERO vs NOC
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Aerospace & Defense
Medical - Devices
Aerospace & Defense
GEVO vs LMT vs RTX vs VERO vs NOC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Aerospace & Defense | Aerospace & Defense | Medical - Devices | Aerospace & Defense |
| Market Cap | $493M | $118.09B | $238.07B | $499K | $78.41B |
| Revenue (TTM) | $174M | $75.11B | $90.37B | $59M | $42.37B |
| Net Income (TTM) | $-11M | $4.79B | $7.26B | $-55M | $4.58B |
| Gross Margin | 23.4% | 9.8% | 20.2% | 64.4% | 20.5% |
| Operating Margin | -4.6% | 9.9% | 10.4% | -59.0% | 11.1% |
| Forward P/E | — | 17.1x | 25.5x | — | 19.8x |
| Total Debt | $168M | $21.70B | $39.51B | $43M | $19.74B |
| Cash & Equiv. | $1M | $4.12B | $7.43B | $4M | $4.40B |
GEVO vs LMT vs RTX vs VERO vs NOC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
| Lockheed Martin Cor… (LMT) | 100 | 131.9 | +31.9% |
| RTX Corporation (RTX) | 100 | 274.0 | +174.0% |
| Venus Concept Inc. (VERO) | 100 | 0.1 | -99.9% |
| Northrop Grumman Co… (NOC) | 100 | 164.7 | +64.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEVO vs LMT vs RTX vs VERO vs NOC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEVO is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs VERO's -15.1%
- +88.0% vs VERO's -88.5%
LMT ranks third and is worth considering specifically for income & stability.
- Dividend streak 23 yrs, beta 0.12, yield 2.6%
- Lower P/E (17.1x vs 19.8x)
- 2.6% yield, 23-year raise streak, vs NOC's 1.6%, (2 stocks pay no dividend)
RTX is the clearest fit if your priority is long-term compounding.
- 234.7% 10Y total return vs NOC's 186.0%
Among these 5 stocks, VERO doesn't own a clear edge in any measured category.
NOC carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.03, current ratio 1.09x
- Beta 0.03, yield 1.6%, current ratio 1.09x
- 10.8% margin vs VERO's -92.8%
- Beta 0.03 vs GEVO's 1.64
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs VERO's -15.1% | |
| Value | Lower P/E (17.1x vs 19.8x) | |
| Quality / Margins | 10.8% margin vs VERO's -92.8% | |
| Stability / Safety | Beta 0.03 vs GEVO's 1.64 | |
| Dividends | 2.6% yield, 23-year raise streak, vs NOC's 1.6%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +88.0% vs VERO's -88.5% | |
| Efficiency (ROA) | 9.1% ROA vs VERO's -88.6%, ROIC 10.2% vs -39.8% |
GEVO vs LMT vs RTX vs VERO vs NOC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEVO vs LMT vs RTX vs VERO vs NOC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LMT leads in 3 of 6 categories
NOC leads 1 • RTX leads 1 • GEVO leads 0 • VERO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NOC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RTX is the larger business by revenue, generating $90.4B annually — 1535.0x VERO's $59M. NOC is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to VERO's -92.8%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $174M | $75.1B | $90.4B | $59M | $42.4B |
| EBITDAEarnings before interest/tax | $18M | $8.7B | $13.8B | -$31M | $6.2B |
| Net IncomeAfter-tax profit | -$11M | $4.8B | $7.3B | -$55M | $4.6B |
| Free Cash FlowCash after capex | -$35M | $5.7B | $8.4B | -$21M | $3.3B |
| Gross MarginGross profit ÷ Revenue | +23.4% | +9.8% | +20.2% | +64.4% | +20.5% |
| Operating MarginEBIT ÷ Revenue | -4.6% | +9.9% | +10.4% | -59.0% | +11.1% |
| Net MarginNet income ÷ Revenue | -6.6% | +6.4% | +8.0% | -92.8% | +10.8% |
| FCF MarginFCF ÷ Revenue | -19.9% | +7.5% | +9.2% | -35.2% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +47.5% | +0.3% | +8.7% | -8.2% | +4.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.8% | -11.5% | +32.5% | -8.5% | +84.9% |
Valuation Metrics
LMT leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 19.0x trailing earnings, NOC trades at a 47% valuation discount to RTX's 35.6x P/E. On an enterprise value basis, LMT's 16.1x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $493M | $118.1B | $238.1B | $498,989 | $78.4B |
| Enterprise ValueMkt cap + debt − cash | $659M | $135.7B | $270.1B | $39M | $93.8B |
| Trailing P/EPrice ÷ TTM EPS | -14.50x | 23.84x | 35.64x | -0.00x | 18.98x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.12x | 25.54x | — | 19.76x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.15x |
| EV / EBITDAEnterprise value multiple | 102.12x | 16.07x | 20.96x | — | 16.30x |
| Price / SalesMarket cap ÷ Revenue | 3.07x | 1.57x | 2.69x | 0.01x | 1.87x |
| Price / BookPrice ÷ Book value/share | 1.01x | 17.68x | 3.57x | 0.07x | 4.76x |
| Price / FCFMarket cap ÷ FCF | — | 17.09x | 29.98x | — | 23.71x |
Profitability & Efficiency
LMT leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
LMT delivers a 74.5% return on equity — every $100 of shareholder capital generates $75 in annual profit, vs $-17 for VERO. GEVO carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to VERO's 15.16x. On the Piotroski fundamental quality scale (0–9), RTX scores 8/9 vs GEVO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.4% | +74.5% | +10.9% | -17.4% | +28.1% |
| ROA (TTM)Return on assets | -1.7% | +8.0% | +4.3% | -88.6% | +9.1% |
| ROICReturn on invested capital | -2.8% | +23.9% | +6.7% | -39.8% | +10.2% |
| ROCEReturn on capital employed | -3.1% | +21.3% | +7.9% | -54.2% | +11.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 8 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.36x | 3.23x | 0.59x | 15.16x | 1.18x |
| Net DebtTotal debt minus cash | $166M | $17.6B | $32.1B | $39M | $15.3B |
| Cash & Equiv.Liquid assets | $1M | $4.1B | $7.4B | $4M | $4.4B |
| Total DebtShort + long-term debt | $168M | $21.7B | $39.5B | $43M | $19.7B |
| Interest CoverageEBIT ÷ Interest expense | -0.04x | 6.08x | 5.58x | -9.69x | 8.92x |
Total Returns (Dividends Reinvested)
RTX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RTX five years ago would be worth $22,007 today (with dividends reinvested), compared to $9 for VERO. Over the past 12 months, GEVO leads with a +88.0% total return vs VERO's -88.5%. The 3-year compound annual growth rate (CAGR) favors RTX at 24.5% vs VERO's -79.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -1.5% | +3.8% | -5.2% | -82.3% | -5.3% |
| 1-Year ReturnPast 12 months | +88.0% | +11.6% | +40.8% | -88.5% | +15.5% |
| 3-Year ReturnCumulative with dividends | +65.0% | +22.2% | +93.0% | -99.1% | +30.5% |
| 5-Year ReturnCumulative with dividends | -65.2% | +46.9% | +120.1% | -99.9% | +59.3% |
| 10-Year ReturnCumulative with dividends | -98.6% | +156.2% | +234.7% | -100.0% | +186.0% |
| CAGR (3Y)Annualised 3-year return | +18.2% | +6.9% | +24.5% | -79.4% | +9.3% |
Risk & Volatility
Evenly matched — RTX and NOC each lead in 1 of 2 comparable metrics.
Risk & Volatility
NOC is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RTX currently trades 82.4% from its 52-week high vs VERO's 2.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.64x | 0.12x | 0.51x | 1.43x | 0.03x |
| 52-Week HighHighest price in past year | $2.97 | $692.00 | $214.50 | $12.93 | $774.00 |
| 52-Week LowLowest price in past year | $1.01 | $410.11 | $126.03 | $0.26 | $453.01 |
| % of 52W HighCurrent price vs 52-week peak | +68.4% | +74.0% | +82.4% | +2.1% | +71.3% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 28.0 | 37.3 | 42.9 | 19.8 |
| Avg Volume (50D)Average daily shares traded | 4.5M | 1.5M | 5.3M | 9K | 760K |
Analyst Outlook
LMT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GEVO as "Buy", LMT as "Buy", RTX as "Buy", NOC as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs 23.9% for LMT (target: $635). For income investors, LMT offers the higher dividend yield at 2.63% vs RTX's 1.49%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | $3.50 | $635.11 | $224.89 | — | $731.46 |
| # AnalystsCovering analysts | 14 | 37 | 26 | — | 35 |
| Dividend YieldAnnual dividend ÷ price | — | +2.6% | +1.5% | — | +1.6% |
| Dividend StreakConsecutive years of raises | — | 23 | 4 | — | 22 |
| Dividend / ShareAnnual DPS | — | $13.50 | $2.63 | — | $8.99 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.5% | +0.0% | 0.0% | +2.1% |
LMT leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). NOC leads in 1 (Income & Cash Flow). 1 tied.
GEVO vs LMT vs RTX vs VERO vs NOC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GEVO or LMT or RTX or VERO or NOC a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -15. 1% for Venus Concept Inc. (VERO). Northrop Grumman Corporation (NOC) offers the better valuation at 19. 0x trailing P/E (19. 8x forward), making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEVO or LMT or RTX or VERO or NOC?
On trailing P/E, Northrop Grumman Corporation (NOC) is the cheapest at 19.
0x versus RTX Corporation at 35. 6x. On forward P/E, Lockheed Martin Corporation is actually cheaper at 17. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GEVO or LMT or RTX or VERO or NOC?
Over the past 5 years, RTX Corporation (RTX) delivered a total return of +120.
1%, compared to -99. 9% for Venus Concept Inc. (VERO). Over 10 years, the gap is even starker: RTX returned +234. 7% versus VERO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEVO or LMT or RTX or VERO or NOC?
By beta (market sensitivity over 5 years), Northrop Grumman Corporation (NOC) is the lower-risk stock at 0.
03β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 5650% more volatile than NOC relative to the S&P 500. On balance sheet safety, Gevo, Inc. (GEVO) carries a lower debt/equity ratio of 36% versus 15% for Venus Concept Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEVO or LMT or RTX or VERO or NOC?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -15. 1% for Venus Concept Inc. (VERO). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -869. 0% for Venus Concept Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEVO or LMT or RTX or VERO or NOC?
Northrop Grumman Corporation (NOC) is the more profitable company, earning 10.
0% net margin versus -72. 5% for Venus Concept Inc. — meaning it keeps 10. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LMT leads at 10. 3% versus -41. 9% for VERO. At the gross margin level — before operating expenses — VERO leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEVO or LMT or RTX or VERO or NOC more undervalued right now?
On forward earnings alone, Lockheed Martin Corporation (LMT) trades at 17.
1x forward P/E versus 25. 5x for RTX Corporation — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.
08Which pays a better dividend — GEVO or LMT or RTX or VERO or NOC?
In this comparison, LMT (2.
6% yield), NOC (1. 6% yield), RTX (1. 5% yield) pay a dividend. GEVO, VERO do not pay a meaningful dividend and should not be held primarily for income.
09Is GEVO or LMT or RTX or VERO or NOC better for a retirement portfolio?
For long-horizon retirement investors, Northrop Grumman Corporation (NOC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
03), 1. 6% yield, +186. 0% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NOC: +186. 0%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEVO and LMT and RTX and VERO and NOC?
These companies operate in different sectors (GEVO (Basic Materials) and LMT (Industrials) and RTX (Industrials) and VERO (Healthcare) and NOC (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GEVO is a small-cap high-growth stock; LMT is a mid-cap quality compounder stock; RTX is a large-cap quality compounder stock; VERO is a small-cap quality compounder stock; NOC is a mid-cap quality compounder stock. LMT, RTX, NOC pay a dividend while GEVO, VERO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.